Abstract
Drug delivery of potential neuropharmaceuticals with poor intrinsic permeability through the blood-brain barrier (BBB), such as peptides, is facilitated by coupling to a vector that undergoes receptor-mediated transcytosis through the endothelial cells of brain microvessels. When cleavable disulfide linkers are used in the synthesis of such "chimeric peptides", it is crucial that the S-S-bridge is stable during transcytosis. Cleavage within endothelial cells could result in sequestration of the drug moiety instead of passage through the BBB. In the present study the metabolically stable opioid peptide [3 H]DALDA ([3 H]Tyr-DArg-Phe-Lys-NH2 ) was used as a model drug. It was monobiotinylated with the cleavable biotin reagent sulfosuccinimidyl 2-(biotinamido)ethyl-1,3'-dithiopropionate (NHS-SS-biotin) to obtain bio-[3 H]DALDA. The biotinylated peptide was then bound to a vector for brain delivery after intravenous injection in rats, a covalent conjugate of streptavidin and the transferrin receptor monoclonal antibody, OX26. Compared to peptide without vector, brain uptake of bio-[3 H]DALDA after was increased 18-fold to reach 0.12% of the injected dose per g tissue. Transcranial microdialysis was performed for 60 min after an intr...Continue Reading
References
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·L NegriV Erspamer
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P M FridenR M Starzyk
Feb 1, 1990·Endocrinology·W M PardridgeJ L Buciak
Jan 1, 1990·Journal of Pharmacobio-dynamics·Y S KangA Tsuji
Mar 1, 1989·Journal of Medicinal Chemistry·P W SchillerC Lemieux
Sep 1, 1987·Metabolism: Clinical and Experimental·W M PardridgeJ Yang
Jan 1, 1984·Neurochemical Research·F Lasbennes, J Gayet
Jun 1, 1980·Journal of Medicinal Chemistry·V A Levin
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·Y SaitoW M Pardridge
Mar 1, 1995·Bioconjugate Chemistry·U BickelW M Pardridge
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·W M PardridgeY S Kang
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R MandelD Peak
Nov 13, 1998·Journal of Pharmaceutical Sciences·R J BoadoW M Pardridge
Jan 20, 1999·Bioconjugate Chemistry·Y DeguchiW M Pardridge
Citations
Nov 24, 2001·Trends in Neurosciences·I Gozes
Jul 10, 2003·Lancet Neurology·Eain M Cornford, Marcia E Cornford
Oct 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Hui DingJulia Y Ljubimova
Apr 1, 2008·Nanomedicine·Julia Y LjubimovaEggehard Holler
Aug 20, 2014·BioMed Research International·Ravi Kant Upadhyay
Dec 18, 2003·British Journal of Clinical Pharmacology·G A FordS H D Jackson
Jan 10, 2012·Vaccine·Aude GarcelAnne-Laure Favier
Mar 23, 2017·Bioconjugate Chemistry·Devora Cohen-KarniSaadyah Averick
Apr 14, 2009·Bioorganic & Medicinal Chemistry·Shin AokiYoshiyuki Kageyama
Aug 4, 2019·Progress in Neurobiology·Kasper Bendix JohnsenTorben Moos
Nov 22, 2020·Biomaterials·A ZaghmiM A Gauthier